ONCOLYTICS BIOTECH
Live / Registered — Registered and renewed (as of 03 Apr 2025)
What this means for you
Registered since 02 Dec 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Dec 2024).
Record
- Serial number
- 86255710
- Registration number
- 4648775
- Mark type
- Stylized text
- Filed
- 17 Apr 2014
- Published for opposition
- 16 Sept 2014
- Registered
- 02 Dec 2014
- Next maintenance due
- 02 Dec 2024
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials; medical and scientific research services in the field of cancer treatment
Owner
- Oncolytics Biotech Inc., Calgary, Alberta, CA
- Oncolytics Biotech Inc., Calgary, Alberta, CA
- Oncolytics Biotech Inc., Calgary, Alberta, CA
Prior registrations
Prosecution history
- 03 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 03 Apr 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 03 Apr 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 03 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Nov 2024 — TEAS SECTION 8 & 9 RECEIVED
- 02 Dec 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Dec 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Dec 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Mar 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Mar 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Mar 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Dec 2020 — TEAS SECTION 8 & 15 RECEIVED